
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
RHHBY | OTC Markets | USD | Delayed | |
RHHVF | OTC Markets | USD | Delayed | |
ROGz | BATS Europe | CHF | Delayed | |
ROz | BATS Europe | CHF | Delayed | |
0QQ6 | London | CHF | Real-time | |
0QOK | London | CHF | Real-time | |
ROGN | Mexico | MXN | Delayed | |
ROG | Switzerland | CHF | Delayed | |
RO | Switzerland | CHF | Delayed | |
RO | Frankfurt | EUR | Delayed | |
RHO6y | Frankfurt | EUR | Delayed |
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD); and strategic agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize zilebesiran. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
Name | Age | Since | Title |
---|---|---|---|
Bernard J. Poussot | 71 | 2015 | Non-Executive Independent Director |
Andre S. Hoffmann | 65 | 1996 | Independent Vice Chairman |
Claudia Suessmuth Dyckerhoff | 56 | 2016 | Non-Executive Independent Director |
Richard P. Lifton | 70 | 2015 | Non-Executive Independent Director |
Jorg Duschmale | 39 | 2020 | Non-Executive Independent Director |
Patrick Frost | 55 | 2020 | Independent Non Executive Director |
Anita Hauser | 54 | 2017 | Non-Executive Independent Director |
Jemilah Mahmood | - | 2022 | Independent Non-Executive Director |
Ulf Mark Schneider | 58 | 2023 | Director |
Akiko Iwasaki | - | 2023 | Director |
Severin Schwan | 56 | 2006 | Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review